We enable cannabis.
Building the largest cannabis platform and offering the most desirable products and brands.
Recently Seen On
Building a flourishing future for cannabis.
We enable strong brands and provide access to high-quality medicinal products through our rapidly growing ecosystem.
As the central platform and trusted partner of the German Cannabis Agency (BfArM) our goal is to continually shape the industry with innovation and diversity.
Cansativa’s vision is built on trust, quality and high-friction transactions for our partners and customers setting the industry standards for excellence.
The ecosystem of trusted
quality services and
Discover more about our exclusive premium medicinal cannabis brand leading our product portfolio.
Discover more about our one-stop-shop for pharmacists to order medical cannabis.
Discover more about our exclusive partnership for the distribution of domestic cultivation.
Cansativa Partner Pharmacies
Discover more about our pharmacy partner program to provide exclusive service for medicinal cannabis patients.
Discover more about our network of leading pharmacies specialized on cannabis.
Cannabis Patient ID
Discover more about the digital identification for medicinal cannabis patients.
Our experts for your business.
Cansativa provides elaborate knowledge within the industry with our diverse team of experts from various fields.
We develop a dependable and diversified product and service landscape alongside our international partners, governmental bodies, administrators and customers.
Our team enables an innovative future for a new industry of enormous potential.
Leading the industry with excellency
on average 20% market share with overall 2,5t distributed volume in 2022
Providing brand & product portfolio variety
continuous portfolio expansion with 400+ SKU
Connecting supply & customers
over 40+ international suppliers and 2k+ active customers
Managing government contract
with over 10t exclusive contract value of domestic supply
Innovating leading technologies
cannabis platform innovation for the industry
with turnover of €13m+ in net revenue in 2022
We are pioneers, believers, executers, leaders -
and brothers. We are enablers.
– Benedikt & Jakob Sons, Founders & Managing Directors
With Jakob as a former lawyer and Benedikt as a former strategy consultant, our founders complement each other with their different professional backgrounds. They combine multi-faceted expertise and a strong entrepreneurial spirit with a common set of values, which is the key to our success. As a result, they are able to consider all aspects of the cannabis market and to act responsibly.
Together, they aim to become enablers of a potent young cannabis industry. They want to pave the way for young companies and make Germany the frontrunner of a safe European cannabis ecosystem.
“We are pioneers and strong executers since 2017. We have built the leading cannabis platform with the biggest supplier and customer network.
We are proud to offer the most desirable cannabis products and brands including the biggest multi-brand portfolio.”
Benedikt Sons, Founder, Managing Director & CEO
„As the market leader in the medical cannabis industry and exclusive partner of the Federal Republic of Germany, we have shaped the German cannabis industry while meeting high regulatory standards.
We now strive to implement swift liberalization in a professional, safe, comprehensive and responsible manner."
Jakob Sons, Founder & Managing Director
Public Affairs – fostering knowledge transfer between industry and public stakeholders.
Our public affairs team aspires to be a leader in responsibility and transparency in the public policy process regarding medicinal cannabis and the upcoming cannabis legalization for adult-use.
We are committed to open and transparent discussions that advance the discourse on facts, create a safe and better future for our partners, customers and patients in order to promote trust in the European cannabis industry. In addition to our focus on ethical business practices, we prioritize compliance with all relevant laws and regulations in the industry, including registering our lobbying activities and working in accordance with state code of conduct.
Find out more about current topics in our knowledge hub.
Receiving insights on most current topics.
Cansativa Group is the market leader in the medical cannabis market and sees itself as a driving force of the cannabis industry in Germany. Since the award by the Federal Institute for Drugs and Medical Devices (BfArM) in August 2020, they are the only company commissioned for the distribution of medical cannabis from German cultivation.
In the upcoming cannabis legalization, Cansativa Group sees itself as a pioneer in the democratization of the cannabis market.
Visit our press department for our mediakit.
Newest partnership to enable export of medical cannabis in the Czech Republic. Cansativa, Tilray and Olikla
AMICI takes the next step – leading the premium medical cannabis market with new THC levels.
The changes to the pharmaceutical guidelines by the G-BA carry great risks